BackIntercept Pharmaceuticals Overview

Intercept Pharmaceuticals Inventory

Intercept Pharmaceuticals's inventory is $2.6M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$2.65M

Peer average / median

Loading

Intercept Pharmaceuticals Inventory History

Loading

Intercept Pharmaceuticals vs. peers: Inventory Comparison

Loading

Intercept Pharmaceuticals Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Intercept Pharmaceuticals (ICPT) FAQ

Intercept Pharmaceuticals (ICPT) currently reports a inventory of $2.6M as of September 2023. In the prior-year period, the figure was $0. Use the charts on this page to explore Intercept Pharmaceuticals's inventory history and peer comparisons.

Intercept Pharmaceuticals's inventory changed from $0 to $2.6M (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Intercept Pharmaceuticals reported $2.6M in inventory as of September 2023. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $2.6M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Intercept Pharmaceuticals, and consider following ICPT for alerts when major investors trade the stock.

Intercept Pharmaceuticals is classified in the Healthcare sector. On inventory, it currently shows $2.6M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ICPT with unrelated industries.